MIR vs. CLBT, INTR, NABL, FA, WNS, PAY, RAMP, EVTC, LSPD, and HNI
Should you be buying Mirion Technologies stock or one of its competitors? The main competitors of Mirion Technologies include Cellebrite DI (CLBT), Inter & Co, Inc. (INTR), N-able (NABL), First Advantage (FA), WNS (WNS), Paymentus (PAY), LiveRamp (RAMP), EVERTEC (EVTC), Lightspeed Commerce (LSPD), and HNI (HNI). These companies are all part of the "business services" sector.
Mirion Technologies (NYSE:MIR) and Cellebrite DI (NASDAQ:CLBT) are both mid-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, community ranking, institutional ownership, valuation, dividends and profitability.
Cellebrite DI received 17 more outperform votes than Mirion Technologies when rated by MarketBeat users. However, 72.73% of users gave Mirion Technologies an outperform vote while only 53.19% of users gave Cellebrite DI an outperform vote.
Mirion Technologies has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500.
Mirion Technologies has a net margin of -9.87% compared to Cellebrite DI's net margin of -24.94%. Cellebrite DI's return on equity of 173.14% beat Mirion Technologies' return on equity.
78.5% of Mirion Technologies shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 2.2% of Mirion Technologies shares are owned by insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Mirion Technologies presently has a consensus target price of $14.00, indicating a potential upside of 34.49%. Cellebrite DI has a consensus target price of $12.42, indicating a potential upside of 12.37%. Given Mirion Technologies' higher possible upside, research analysts plainly believe Mirion Technologies is more favorable than Cellebrite DI.
In the previous week, Cellebrite DI had 3 more articles in the media than Mirion Technologies. MarketBeat recorded 4 mentions for Cellebrite DI and 1 mentions for Mirion Technologies. Cellebrite DI's average media sentiment score of 1.38 beat Mirion Technologies' score of 0.00 indicating that Cellebrite DI is being referred to more favorably in the news media.
Cellebrite DI has lower revenue, but higher earnings than Mirion Technologies. Cellebrite DI is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Cellebrite DI beats Mirion Technologies on 10 of the 17 factors compared between the two stocks.
Get Mirion Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for MIR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mirion Technologies Competitors List
Related Companies and Tools
